
<style>
    * {
        box-sizing: border-box !important;
    }

    body {
        font-family: 'Inter', 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif !important;
        line-height: 1.9 !important;
        color: #1f1f1f !important;
        max-width: none !important;
        margin: 0 !important;
        padding: 8px 16px 16px 16px !important;
        background: #ffffff !important;
        font-size: 16.5px !important;
    }

    p {
        margin-bottom: 20px !important;
        font-size: 16.5px !important;
        line-height: 1.95 !important;
        color: #1f1f1f !important;
        font-weight: 400 !important;
    }

    strong, b {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        background: rgba(26, 115, 232, 0.08) !important;
        padding: 2px 6px !important;
        border-radius: 8px !important;
    }

    /* Details/Summary (collapsible sections) */
    details {
        background: linear-gradient(135deg, #f8f9fa 0%, #ffffff 100%) !important;
        border-radius: 8px !important;
        padding: 24px 28px !important;
        margin: 24px 0 !important;
        border: none;
        box-shadow: none !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
    }

    details:hover {
        border-color: #1a73e8 !important;
        box-shadow: none !important;
        transform: translateY(-2px) !important;
    }

    details[open] {
        background: #ffffff !important;
        border-color: #1a73e8 !important;
        box-shadow: none !important;
    }

    summary {
        cursor: pointer !important;
        font-weight: 800 !important;
        color: #ffffff !important;
        font-size: 20px !important;
        padding: 16px 24px !important;
        border-radius: 8px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
        display: flex !important;
        align-items: center !important;
        user-select: none !important;
        box-shadow: none !important;
        letter-spacing: 0.5px !important;
    }

    summary:hover {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        transform: translateX(6px) scale(1.02) !important;
        box-shadow: none !important;
    }

    summary:active {
        transform: translateX(4px) scale(0.99) !important;
    }

    summary::marker {
        color: rgba(255, 255, 255, 0.9) !important;
        font-size: 1.3em !important;
    }

    summary strong {
        background: rgba(255, 255, 255, 0.2) !important;
        color: #ffffff !important;
        padding: 4px 12px !important;
        border-radius: 8px !important;
        margin-left: 8px !important;
        font-size: 19px !important;
        letter-spacing: 1px !important;
    }

    /* Tables - Premium Design */
    table {
        width: 100% !important;
        border-collapse: separate !important;
        border-spacing: 0 !important;
        margin: 28px 0 !important;
        border-radius: 8px !important;
        overflow: hidden !important;
        box-shadow: none !important;
        border: none !important;
        background: #ffffff !important;
    }

    table.simple-table {
        background: linear-gradient(135deg, #ffffff 0%, #f8f9fa 100%) !important;
    }

    table tr {
        transition: all 0.25s cubic-bezier(0.4, 0, 0.2, 1) !important;
        position: relative !important;
    }

    table tr:nth-child(odd) {
        background: rgba(248, 249, 250, 0.5) !important;
    }

    table tr:nth-child(even) {
        background: rgba(255, 255, 255, 0.8) !important;
    }

    table tr:hover {
        background: linear-gradient(90deg, #e8f0fe 0%, #f1f8ff 100%) !important;
        transform: translateX(4px) scale(1.01) !important;
        box-shadow: none !important;
        z-index: 1 !important;
    }

    table td {
        padding: 18px 24px !important;
        border-bottom: 1px solid rgba(232, 234, 237, 0.6) !important;
        font-size: 16.5px !important;
        line-height: 1.7 !important;
        color: #1f1f1f !important;
        vertical-align: middle !important;
    }

    table tr:last-child td {
        border-bottom: none !important;
    }

    /* First column (A, B, C, D, E) */
    table td:first-child {
        font-weight: 800 !important;
        color: #ffffff !important;
        width: 52px !important;
        text-align: center !important;
        font-size: 18px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        border-right: 3px solid #1557b0 !important;
        position: relative !important;
        letter-spacing: 0.5px !important;
    }

    table tr:hover td:first-child {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        box-shadow: none !important;
    }

    /* Second column (content) */
    table td:nth-child(2) {
        font-weight: 500 !important;
        padding-left: 28px !important;
    }

    /* Third column (empty - hide it) */
    table td:last-child:empty {
        display: none !important;
    }

    /* Lists */
    ul, ol {
        margin: 16px 0 !important;
        padding-left: 32px !important;
    }

    li {
        margin: 10px 0 !important;
        line-height: 1.8 !important;
        color: #1f1f1f !important;
    }

    ul.bulleted-list li {
        position: relative !important;
        padding-left: 8px !important;
    }

    ul.toggle {
        list-style: none !important;
        padding-left: 0 !important;
    }

    /* Links */
    a {
        color: #1a73e8 !important;
        text-decoration: none !important;
        font-weight: 600 !important;
        border-bottom: 2px solid transparent !important;
        transition: all 0.2s !important;
    }

    a:hover {
        border-bottom-color: #1a73e8 !important;
        background: rgba(26,115,232,0.08) !important;
        padding: 2px 4px !important;
        border-radius: 8px !important;
    }

    /* Images & Media */
    img, video {
        max-width: none !important;
        height: auto !important;
        border-radius: 8px !important;
        box-shadow: none !important;
        margin: 24px 0 !important;
        display: block !important;
        border: none !important;
    }

    img:hover, video:hover {
        box-shadow: none !important;
        border-color: #1a73e8 !important;
    }

    /* Code blocks (if any) */
    code {
        background: #f1f3f4 !important;
        padding: 2px 8px !important;
        border-radius: 8px !important;
        font-family: 'Courier New', monospace !important;
        font-size: 14px !important;
        color: #d93025 !important;
    }

    pre {
        background: #f8f9fa !important;
        padding: 8px 16px 16px 16px !important;
        border-radius: 8px !important;
        overflow-x: auto !important;
        border-left: 4px solid #1a73e8 !important;
    }

    /* Headings */
    h1, h2, h3, h4, h5, h6 {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        margin-top: 24px !important;
        margin-bottom: 16px !important;
        line-height: 1.4 !important;
    }

    h1 { font-size: 32px !important; }
    h2 { font-size: 26px !important; }
    h3 { font-size: 22px !important; }
    h4 { font-size: 19px !important; }

    /* Blockquotes */
    blockquote {
        border-left: 4px solid #1a73e8 !important;
        padding-left: 20px !important;
        margin: 20px 0 !important;
        font-style: italic !important;
        color: #5f6368 !important;
        background: #f8f9fa !important;
        padding: 16px 20px !important;
        border-radius: 8px !important;
    }

    /* Horizontal Rule */
    hr {
        border: none !important;
        height: 2px !important;
        background: linear-gradient(to right, transparent, #1a73e8, transparent) !important;
        margin: 32px 0 !important;
    }

    /* Selection */
    ::selection {
        background: #e8f0fe !important;
        color: #1a73e8 !important;
    }

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>




<details open>
<summary><strong>1565</strong><button class="bionic-reading-btn" onclick="toggleBionicReading(event)" title="Toggle Bionic Reading (Ctrl+B)"><span id="bionicIcon">üëÅÔ∏è</span></button><button class="highlighter-btn" onclick="toggleHighlighter(event)" title="Toggle Highlighter (Ctrl+H)"><span id="highlighterIcon">üñäÔ∏è</span></button></summary>
<p class="" id="bb579f20-e3d5-4f10-9b2f-5976ebde2fe9">A 58-year-old man comes to the
                                        office due to progressive fatigue, dyspnea on exertion, and orthopnea.  Medical
                                        history is significant for hypertension, hyperlipidemia, and a myocardial
                                        infarction 2 years ago.  The patient says he has not taken his medications in
                                        several months because he was "feeling well."  Blood pressure is
                                        160/95 mm Hg and pulse is 94/min and regular.  Physical examination shows
                                        bilateral lung crackles and lower extremity edema.  The point of maximal impulse
                                        is displaced toward the axilla, and an S3 is heard.  Serum creatinine is 0.9
                                        mg/dL and serum potassium is 4.2 mEq/L.  After this patient's condition has
                                        stabilized, long-term use of which of the following medications will most likely
                                        reduce mortality?</p>
<table class="simple-table" id="bd4552be-c5cb-469d-93a3-a70ec5ea2eb7">
<tbody>
<tr id="fec1adb8-3c70-4a0c-9a2e-a96bc016570c">
<td class="" id="y~xq">A.</td>
<td class="" id="}kvR">Amlodipine</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="c83d587f-82b6-40ab-8272-6eaddc0a3515">
<td class="" id="y~xq">B.</td>
<td class="" id="}kvR">Digoxin</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="2d1de7ac-6ef6-4519-ac7d-e13bf1f6c66c">
<td class="" id="y~xq">C.</td>
<td class="" id="}kvR">Diltiazem</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="076215b0-c7ca-4b53-90f4-7593ef0fbbf8">
<td class="" id="y~xq">D.</td>
<td class="" id="}kvR">Furosemide</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="3fe668dd-99d8-4f42-bdc1-8bbc1342aeb9">
<td class="" id="y~xq">E.</td>
<td class="" id="}kvR">Hydrochlorothiazide</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="5be3845e-4509-4ca4-bdc7-10729f56b360">
<td class="" id="y~xq">F.</td>
<td class="" id="}kvR">Lisinopril</td>
<td class="" id="d_T]"></td>
</tr>
<tr id="a7c6c23e-1285-476f-a794-6fda62624435">
<td class="" id="y~xq">G.</td>
<td class="" id="}kvR">Triamterene</td>
<td class="" id="d_T]"></td>
</tr>
</tbody>
</table>
<ul class="toggle" id="38da31d5-91c2-4b8c-80ad-251850cf0e44">
<li>
<details>
<summary>Submit</summary>
<table class="simple-table" id="b67535ec-c3cc-4496-9e54-63eb85a3a53c">
<tbody>
<tr id="0f5a6b6e-de84-4cef-a672-686464f0859e">
<td class="" id=":Ml~"><strong>A.</strong></td>
<td class="" id="RCXS"><strong>Amlodipine (3%)</strong></td>
<td class="" id="^PQX"></td>
</tr>
<tr id="d253d41c-224f-40b0-9a15-7fa896dae5f9">
<td class="" id=":Ml~"><strong>B.</strong></td>
<td class="" id="RCXS"><strong>Digoxin (4%)</strong></td>
<td class="" id="^PQX"></td>
</tr>
<tr id="0243f759-4103-4222-b966-fdbc3625ba04">
<td class="" id=":Ml~"><strong>C.</strong></td>
<td class="" id="RCXS"><strong>Diltiazem (2%)</strong></td>
<td class="" id="^PQX"></td>
</tr>
<tr id="c7a2a718-a1de-41bf-a9ff-ba3b513e464c">
<td class="" id=":Ml~"><strong>D.</strong></td>
<td class="" id="RCXS"><strong>Furosemide (9%)</strong></td>
<td class="" id="^PQX"></td>
</tr>
<tr id="273a882c-aaf5-43dc-878c-1916d60a35e2">
<td class="" id=":Ml~"><strong>E.</strong></td>
<td class="" id="RCXS"><strong>Hydrochlorothiazide
                                                                    (6%)</strong></td>
<td class="" id="^PQX"></td>
</tr>
<tr id="2b3c7715-64e5-4d21-89ff-bed4821b3bbe">
<td class="" id=":Ml~"><strong>F.</strong></td>
<td class="" id="RCXS"><strong>Lisinopril (69%)</strong>
</td>
<td class="" id="^PQX"></td>
</tr>
<tr id="207b2cfd-72f2-4299-a65f-38a73f0b1f78">
<td class="" id=":Ml~"><strong>G.</strong></td>
<td class="" id="RCXS"><strong>Triamterene (3%)</strong>
</td>
<td class="" id="^PQX"></td>
</tr>
</tbody>
</table>
<p class="" id="54442c7e-6b7e-461e-97a2-0e5c17685fb2">
<strong>Incorrect</strong></p>
<p class="" id="024fc6f6-52dd-4138-8044-6038bb9cfa77"><strong>Correct
                                                        answer F</strong></p>
<p class="" id="74b65de7-ce7c-44aa-ab86-610e23d2201c">
<strong>69%Answered correctly</strong></p>
<p class="" id="0d3a5834-e215-4cde-9c48-a39acca63b3f"><strong>21
                                                        secsTime Spent</strong></p>
<p class="" id="3b09e947-be01-4991-bca9-641f01a8baba">
<strong>2024Version</strong></p>
<ul class="bulleted-list" id="7ab42b83-9292-4172-8e4e-a7ce556a155b">
<li style="list-style-type:disc"><strong>Explanation</strong></li>
</ul>
<ul class="bulleted-list" id="60d358e8-7c65-40bf-bed7-c11367b611ec">
<li style="list-style-type:disc"></li>
</ul>
<table class="simple-table" id="0582eb5f-7be7-47cd-aaef-f1726b13d149">
<tbody>
<tr id="28e0c1d6-367a-4ece-9766-0663ed26a290">
<td class="" id="cEW;"><strong>Pharmacotherapy for chronic
                                                                    heart failure with reduced ejection
                                                                    fraction</strong></td>
<td class="" id="RH]S"></td>
</tr>
<tr id="a6267475-6224-4d16-bfdf-90d7c1b81823">
<td class="" id="cEW;"><strong>Agent</strong></td>
<td class="" id="RH]S"><strong>Mortality benefit</strong>
</td>
</tr>
<tr id="7c86344d-d175-4f7e-b990-54b2b7a65893">
<td class="" id="cEW;"><strong>Angiotensin
                                                                    receptor-neprilysin
                                                                    inhibitor</strong><br/><br/><strong>(eg,
                                                                    sacubitril-valsartan)</strong><br/><br/><strong>OR</strong><br/><br/><strong>ACE
                                                                    inhibitor</strong><br/><br/><strong>(eg,
                                                                    lisinopril)</strong><br/><br/><strong>OR</strong><br/><br/><strong>Angiotensin
                                                                    II receptor blocker</strong><br/><br/><strong>(eg,
                                                                    losartan)</strong></td>
<td class="" id="RH]S"><strong>Yes</strong></td>
</tr>
<tr id="863d4d3b-3b43-40b3-8830-3160702c37dc">
<td class="" id="cEW;"><strong>Beta
                                                                    blocker</strong><br/><br/><strong>(eg, metoprolol,
                                                                    carvedilol)</strong></td>
<td class="" id="RH]S"><strong>Yes</strong></td>
</tr>
<tr id="264cddaf-abce-4115-b77f-71dac88d32c3">
<td class="" id="cEW;"><strong>Mineralocorticoid receptor
                                                                    antagonist</strong><br/><br/><strong>(eg,
                                                                    spironolactone, eplerenone)</strong></td>
<td class="" id="RH]S"><strong>Yes</strong></td>
</tr>
<tr id="8a67ae2f-0ca5-44b8-9f1e-36129d4c7404">
<td class="" id="cEW;"><strong>Sodium-glucose
                                                                    cotransporter-2
                                                                    inhibitor</strong><br/><br/><strong>(eg,
                                                                    dapagliflozin, empagliflozin)</strong></td>
<td class="" id="RH]S"><strong>Yes</strong></td>
</tr>
<tr id="5b8423d4-0db4-47b4-8a41-6d7cb2a5b508">
<td class="" id="cEW;">
<strong>Diuretic</strong><br/><br/><strong>(eg,
                                                                    furosemide, metolazone)</strong></td>
<td class="" id="RH]S"><strong>No*</strong></td>
</tr>
<tr id="a17d4d90-c511-4739-be8c-1afe21eaea1e">
<td class="" id="cEW;"><strong>Digoxin</strong></td>
<td class="" id="RH]S"><strong>No**</strong></td>
</tr>
<tr id="ef018f93-027e-4b00-a2a0-5e2d097f26b6">
<td class="" id="cEW;"><strong>*Improves symptoms &amp;
                                                                    reduces
                                                                    hospitalization.</strong><br/><br/><strong>**Reduces
                                                                    hospitalization.</strong></td>
<td class="" id="RH]S"></td>
</tr>
</tbody>
</table>
<p class="" id="0fe05845-6c0a-4972-a2c1-f276775508d7"><strong>This
                                                        patient with a previous myocardial infarction has most likely
                                                        developed chronic heart failure with reduced ejection fraction
                                                        (HFrEF).  Appropriate pharmacologic management is important in
                                                        such patients because it has been shown to reduce mortality. 
                                                        Much of this mortality benefit is likely related to a reduction
                                                        in deleterious cardiac remodeling.</strong></p>
<p class="" id="84ab01d5-1156-4084-8c01-58de7ff3706a">
<strong>Neurohormonal pathways involving norepinephrine, angiotensin
                                                        II, and aldosterone all have a demonstrated role in cardiac
                                                        remodeling.  In particular, elevated angiotensin II and
                                                        aldosterone levels increase pathologic cardiomyocyte hypertrophy
                                                        and stimulate collagen deposition by fibroblasts (cardiac
                                                        fibrosis).  Accordingly, ACE inhibitors (eg, lisinopril),
                                                        angiotensin-receptor blockers (eg, losartan), and
                                                        mineralocorticoid receptor antagonists (eg, spironolactone,
                                                        epleronone) reduce mortality in patients with HFrEF via a
                                                        reduction in angiotensin II‚Äìmediated (and downstream
                                                        aldosterone-mediated) cardiac remodeling.</strong></p>
<p class="" id="ac5c04eb-198e-4b7c-b071-5e9a25baefca"><strong>Beta
                                                        blockers (eg, metoprolol, carvedilol) also reduce mortality in
                                                        patients with chronic HFrEF, likely through similar inhibition
                                                        of neurohormonal mechanisms.  Potentiation of the natriuretic
                                                        peptide neurohormonal pathway with angiotensin
                                                        receptor-neprilysin inhibitor therapy (eg, sacubitril-valsartan)
                                                        has also demonstrated mortality benefit in these
                                                        patients.</strong></p>
<p class="" id="49435f32-56c0-4c07-9d6e-32b5165d572e"><strong>(Choice
                                                        A)  Blood pressure control is important for patients with heart
                                                        failure because it slows the progression of coronary artery
                                                        disease and may reduce cardiac remodeling that is triggered by
                                                        increased left ventricular pressure load.  However, aside from
                                                        the benefit of blood pressure reduction, dihydropyridine calcium
                                                        channel blockers (eg, amlodipine) provide no additional
                                                        mortality benefit in patients with HFrEF.</strong></p>
<p class="" id="68cdeebd-72a6-4b17-9f98-5b0dda9b00cf"><strong>(Choice
                                                        B)  Digoxin is used as an adjunctive therapy in patients with
                                                        HFrEF.  It improves symptoms, thereby reducing the rate of
                                                        hospitalization, but does not improve mortality.</strong></p>
<p class="" id="2ae0f9f6-06c0-4d77-8920-129d35a5b949"><strong>(Choice
                                                        C)  Nondihydropyridine calcium channel blockers (eg, verapamil,
                                                        diltiazem) can depress cardiac contractility and are usually
                                                        contraindicated in patients with HFrEF.</strong></p>
<p class="" id="fcf1887d-8584-422c-a432-47b871e648e2"><strong>(Choices D
                                                        and E)  Loop (eg, furosemide) and thiazide (eg, metolazone)
                                                        diuretics reduce cardiac preload and are useful for symptomatic
                                                        management of patients with HFrEF; however, these drugs do not
                                                        provide a clear mortality benefit.</strong></p>
<p class="" id="d5492488-7975-4b37-a5c9-93ecde8a730b"><strong>(Choice
                                                        G)  Although potassium-sparing diuretics that function via
                                                        blockade of mineralocorticoid receptors have shown mortality
                                                        benefit for HFrEF, those that act via blockade of the epithelial
                                                        sodium channel (ENaC) (eg, triamterene, amiloride) have minimal
                                                        neurohormonal effects and no demonstrated benefit.</strong></p>
<p class="" id="675d814d-89db-4802-8f53-7a22b80637e9">
<strong>Educational objective:</strong></p>
<p class="" id="e83bb403-d1d2-42b5-95e4-3efe0d89417e">
<strong>Neurohormones (eg, norepinephrine, angiotensin II, and
                                                        aldosterone) play a large role in the deleterious cardiac
                                                        remodeling that occurs in heart failure with reduced ejection
                                                        fraction.  ACE inhibitors, angiotensin-receptor blockers,
                                                        mineralocorticoid receptor antagonists, beta blockers, and
                                                        angiotensin receptor-neprilysin inhibitors reduce mortality in
                                                        these patients by reducing neurohormonal-mediated cardiac
                                                        remodeling.</strong></p>
<p class="" id="de7bd9c4-9d4c-4078-93af-d5b79e510ec5">
<strong>References</strong></p>
<ul class="bulleted-list" id="c8ba64cb-3f24-4935-b007-a3c253a78899">
<li style="list-style-type:disc"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23741057"><strong>2013
                                                                ACCF/AHA guideline for the management of heart failure:
                                                                executive summary: a report of the American College of
                                                                Cardiology Foundation/American Heart Association Task
                                                                Force on practice guidelines.</strong></a></li>
</ul>
<p class="" id="a4aeb20c-c72e-4fbf-8a54-61efb231db0e">
<strong>Pharmacology</strong></p>
<p class="" id="526ff0bb-7bff-456c-be23-1b0cd67cbfe1">
<strong>Subject</strong></p>
<p class="" id="038450f2-d082-4b54-af71-e63324068080">
<strong>Cardiovascular System</strong></p>
<p class="" id="c3c7467f-98a0-4495-9781-471326150267">
<strong>System</strong></p>
<p class="" id="c0231996-4046-4c97-b082-ca06472fa6db"><strong>Chronic
                                                        heart failure</strong></p>
<p class="" id="78339def-f139-4b0c-95c4-5b0fdd726ef7">
<strong>Topic</strong></p>
<p class="" id="b78f3c4a-fcc7-4a73-9ca1-57bc81f4e95a"><strong>Copyright
                                                        ¬© UWorld. All rights reserved.</strong></p>
</details>
</li>
</ul>
</details>


















<style>
.bionic-reading-btn {
    display: inline-flex;
    align-items: center;
    justify-content: center;
    width: 40px;
    height: 40px;
    background: rgba(255, 255, 255, 0.2);
    border: 2px solid rgba(255, 255, 255, 0.3);
    border-radius: 8px;
    color: white;
    font-size: 20px;
    cursor: pointer;
    transition: all 0.3s;
    margin-left: auto;
    flex-shrink: 0;
}

.bionic-reading-btn:hover {
    background: rgba(255, 255, 255, 0.35);
    border-color: rgba(255, 255, 255, 0.5);
    transform: scale(1.1);
}

.bionic-reading-btn.active {
    background: rgba(52, 168, 83, 0.4);
    border-color: rgba(52, 168, 83, 0.6);
}

.bionic-reading-btn.active:hover {
    background: rgba(52, 168, 83, 0.5);
}

summary {
    display: flex !important;
    align-items: center !important;
    gap: 12px !important;
}

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>



<script>
let bionicEnabled = false;
const originalContent = {};

function toggleBionicReading(event) {
    if (event) {
        event.preventDefault();
        event.stopPropagation();
    }

    bionicEnabled = !bionicEnabled;
    const btn = document.querySelector('.bionic-reading-btn');
    const icon = document.getElementById('bionicIcon');

    if (bionicEnabled) {
        btn.classList.add('active');
        icon.textContent = '‚úÖ';
        applyBionicReading();
    } else {
        btn.classList.remove('active');
        icon.textContent = 'üëÅÔ∏è';
        restoreOriginalText();
    }
}

function applyBionicReading() {
    // Seleciona todos os elementos de texto, EXCETO summary e buttons
    const textElements = document.querySelectorAll('p:not(summary p):not(button p), td:not(summary td):not(button td), li:not(summary li):not(button li)');

    textElements.forEach((element, index) => {
        // Ignora elementos que cont√™m outros elementos complexos
        if (element.querySelector('p, td, li, h1, h2, h3, h4, h5, h6, button, summary')) {
            return;
        }

        // Ignora se o elemento est√° dentro de um summary ou button
        if (element.closest('summary') || element.closest('button') || element.closest('.bionic-reading-btn')) {
            return;
        }

        // Salva o conte√∫do original
        if (!originalContent[index]) {
            originalContent[index] = {
                element: element,
                html: element.innerHTML
            };
        }

        // Aplica Bionic Reading
        const bionicText = convertToBionic(element.textContent);
        element.innerHTML = bionicText;
    });
}

function restoreOriginalText() {
    // Restaura o conte√∫do original
    Object.values(originalContent).forEach(item => {
        item.element.innerHTML = item.html;
    });
}

function convertToBionic(text) {
    // Divide o texto em palavras, mantendo pontua√ß√£o
    const words = text.split(/(\s+|[.,;:!?()""''\-‚Äì‚Äî])/);

    const bionicWords = words.map(word => {
        // Ignora espa√ßos e pontua√ß√£o
        if (word.match(/^\s+$/) || word.match(/^[.,;:!?()""''\-‚Äì‚Äî]+$/)) {
            return word;
        }

        // Ignora palavras muito curtas (1-2 letras)
        if (word.length <= 2) {
            return word;
        }

        // Determina quantas letras deixar em negrito (metade da palavra, arredondado para cima)
        const boldLength = Math.ceil(word.length / 2);

        // Separa a parte em negrito da parte normal
        const boldPart = word.substring(0, boldLength);
        const normalPart = word.substring(boldLength);

        // Retorna com a primeira parte em negrito
        return `<strong style="font-weight: 700 !important; color: inherit !important; background: none !important; padding: 0 !important;">${boldPart}</strong>${normalPart}`;
    });

    return bionicWords.join('');
}

// Adiciona atalho de teclado (Ctrl+B ou Cmd+B)
document.addEventListener('keydown', function(e) {
    if ((e.ctrlKey || e.metaKey) && e.key === 'b') {
        e.preventDefault();
        toggleBionicReading();
    }
});
</script>

<script>
    let highlighterActive = false;
    let questionHighlights = {};

    // Get question ID from the first summary strong tag
    function getQuestionId() {
        const firstSummary = document.querySelector('summary strong');
        return firstSummary ? firstSummary.textContent.trim() : '1';
    }

    // Load highlights from localStorage
    function loadHighlights() {
        const questionId = getQuestionId();
        const stored = localStorage.getItem('highlights_' + questionId);
        if (stored) {
            questionHighlights = JSON.parse(stored);
            applyStoredHighlights();
        }
    }

    // Save highlights to localStorage
    function saveHighlights() {
        const questionId = getQuestionId();
        localStorage.setItem('highlights_' + questionId, JSON.stringify(questionHighlights));
    }

    // Apply stored highlights
    function applyStoredHighlights() {
        Object.keys(questionHighlights).forEach(key => {
            const element = document.querySelector(`[data-highlight-id="${key}"]`);
            if (element && questionHighlights[key]) {
                element.classList.add('highlighted');
            }
        });
    }

    // Toggle highlighter mode
    function toggleHighlighter(event) {
        event.stopPropagation();
        highlighterActive = !highlighterActive;

        const btn = event.target.closest('.highlighter-btn');
        const icon = btn.querySelector('#highlighterIcon');

        if (highlighterActive) {
            btn.classList.add('active');
            icon.textContent = 'üñçÔ∏è';
            document.body.classList.add('highlighter-mode-active');
        } else {
            btn.classList.remove('active');
            icon.textContent = 'üñäÔ∏è';
            document.body.classList.remove('highlighter-mode-active');
        }
    }

    // Clear all highlights for this question
    function clearHighlights() {
        const questionId = getQuestionId();
        questionHighlights = {};
        localStorage.removeItem('highlights_' + questionId);
        document.querySelectorAll('.highlighted').forEach(el => {
            el.classList.remove('highlighted');
        });
    }

    // Handle text selection and highlighting
    document.addEventListener('mouseup', function(e) {
        if (!highlighterActive) return;

        const selection = window.getSelection();
        if (!selection.toString().trim()) return;

        const range = selection.getRangeAt(0);
        const container = range.commonAncestorContainer;

        // Only highlight text in paragraphs, not in buttons or other elements
        const paragraph = container.nodeType === 3 ? container.parentElement : container;
        if (paragraph.tagName !== 'P' && paragraph.tagName !== 'LI' && paragraph.tagName !== 'TD') {
            return;
        }

        // Create highlight span
        const span = document.createElement('span');
        span.classList.add('highlighted');

        // Generate unique ID for this highlight
        const highlightId = 'hl-' + Date.now() + '-' + Math.random().toString(36).substr(2, 9);
        span.setAttribute('data-highlight-id', highlightId);

        try {
            range.surroundContents(span);
            questionHighlights[highlightId] = true;
            saveHighlights();
        } catch (e) {
            console.log('Could not highlight selection');
        }

        selection.removeAllRanges();
    });

    // Load highlights when page loads
    window.addEventListener('load', loadHighlights);

    // Keyboard shortcut: Ctrl+H to toggle highlighter
    document.addEventListener('keydown', function(e) {
        if (e.ctrlKey && e.key === 'h') {
            e.preventDefault();
            const btn = document.querySelector('.highlighter-btn');
            if (btn) {
                toggleHighlighter({target: btn, stopPropagation: () => {}});
            }
        }
        // Ctrl+Shift+H to clear all highlights
        if (e.ctrlKey && e.shiftKey && e.key === 'H') {
            e.preventDefault();
            if (confirm('Clear all highlights for this question?')) {
                clearHighlights();
            }
        }
    });
</script>
